Skip to content

TREATMENT ALTERNATIVES FOR SUBFERTILE WOMEN WITH CLASS II ANOVULATION NOT CONCEIVING AFTER SIX OVULATORY CYCLES WITH CLOMIPHENE CITRATE

TREATMENT ALTERNATIVES FOR SUBFERTILE WOMEN WITH CLASS II ANOVULATION NOT CONCEIVING AFTER SIX OVULATORY CYCLES WITH CLOMIPHENE CITRATE - Treatment after six ovulatory cycles with clomiphene

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32596
Enrollment
200
Registered
2008-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anovulation subfertility

Interventions

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients with six ovulatory cycles after CC treatment and no conception. Ovulation is assessed by a midluteal progesterone (> 16 nmol/l), basal temperature curve, detection of LH surge or history. • All patients have normal serum FSH ( 80 pmol/l), prolactin (0,05 - 0,80 IU/l) and thyroid-stimulating hormone (0,4 - 4,0 mU/l). • All women have patent Fallopian tubes, proven by hysterosalpingography (HSG), a negative Chlamydia antibody titre (CAT) or diagnostic laparoscopy combined with tubal testing (DLS and TT). • The partners have normal semen parameters according to the modified criteria of the World Health Organization (1999). • Age between 18 and 40 years.

Exclusion criteria

Exclusion criteria: • Patients who have previously been treated with gonadotropins or IVF are excluded. • Patients are excluded if they have intolerable symptoms when treated with CC like hot flashes affecting daily function, headaches, vision changes, and depression • Patients are excluded if they are remaining anovulatory on CC 150 mg.

Design outcomes

Primary

MeasureTime frame
Pregnancy leading to live birth.

Secondary

MeasureTime frame
clinical pregnancy miscarriage multiple pregnancy occurrence of ovulation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)